FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to novel compounds of formula 1: 
where R is selected from group, consisting of C1-C3alkyls, and to their pharmaceutically acceptable salts. Invention also relates to pharmaceutical composition.
EFFECT: obtaining novel biologically active compounds which possess activity of dopamine neurotransmission modulator.
16 cl, 2 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| NEW DISUBSTITUTED PHENYL PIPERIDINES/PIPERAZINES AS MODULATORS OF DOPAMINE NEUROTRANSMISSION | 2005 |
|
RU2366654C2 |
| NEW MODULATORS OF CORTICAL DOPAMINERGIC AND GLUTAMATERGIC NEUROTRANSMISSION MEDIATED BY NMDA-RECEPTOR | 2012 |
|
RU2593500C2 |
| TREATMENT OF ADDICTION AND IMPULSE-CONTROL DISORDERS USING PDE7 INHIBITORS | 2013 |
|
RU2665134C2 |
| SUBSTITUTED 2-PHENYL-1-(3,4-DIHYDROXY-5-NITROPHENYL)-1-ETHANONES, METHOD FOR TREATMENT OF SOME DISTURBANCES IN CENTRAL AND PERIPHERAL NERVOUS SYSTEM AND PHARMACEUTICAL COMPOSITION CONTAINING INDICATED SUBSTANCES | 1999 |
|
RU2232748C2 |
| SUBSTITUTED 4-(PHENYL-N-ALKYL)PIPERIDINES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS FOR TREATMENT | 2000 |
|
RU2262504C2 |
| NOVEL DOPAMINE NEUROTRANSMISSION MODULATORS | 2000 |
|
RU2386623C2 |
| 3-SUBSTITUTED 4-(PHENYL-N-ALKYL)-PIPERIDINES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHODS FOR TREATMENT | 2000 |
|
RU2265013C2 |
| α-AMINOAMIDE DERIVATIVES EFFECTIVE IN TREATING RESTLESS LEGS SYNDROME AND ADDICTIVE DISORDERS | 2005 |
|
RU2403030C2 |
| USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS | 2010 |
|
RU2600869C2 |
| USING DERIVATIVES OF N-(INDOLCARBONYL)PIPERAZINE | 2002 |
|
RU2317083C2 |
